These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3559968

  • 1. Ascorbic acid prevents nonreceptor "specific" binding of [3H]-5-hydroxytryptamine to bovine cerebral cortex membranes.
    Hamblin MW, Adriaenssens PI, Ariani K, Cawthon RM, Stratford CA, Tan GL, Ciaranello RD.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):701-11. PubMed ID: 3559968
    [Abstract] [Full Text] [Related]

  • 2. Necessity of ascorbic acid in the radioligand binding assay for [3H]5-hydroxytryptamine.
    Andresen JW, Shih JC.
    Neuropharmacology; 1986 Aug; 25(8):869-75. PubMed ID: 3774116
    [Abstract] [Full Text] [Related]

  • 3. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ, Largent BL, Snowman AM, Snyder SH.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [Abstract] [Full Text] [Related]

  • 4. Effects of radioligand oxidation and ascorbate-induced lipid peroxidation on serotonin-1 receptor assay: use of ascorbate and ethylenediamine tetraacetic acid buffers to prevent (3H)-5-HT binding artifacts.
    May PC, Morgan DG, Salo D, Goss JR, Finch CE.
    J Neurosci Res; 1988 Jul; 20(2):257-62. PubMed ID: 3139891
    [Abstract] [Full Text] [Related]

  • 5. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    Sills MA, Wolfe BB, Frazer A.
    Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
    [Abstract] [Full Text] [Related]

  • 6. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO, Bäckström IT, Ross SB.
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [Abstract] [Full Text] [Related]

  • 7. [Increase in binding affinity of the 5-HT receptor and decrease in 5-HT sensitive adenylate cyclase activity following prolonged exposure to 5-HT (author's transl)].
    Fillion G, Fillion MP, Rousselle JC.
    J Physiol (Paris); 1981 Aug; 77(2-3):363-8. PubMed ID: 7288651
    [Abstract] [Full Text] [Related]

  • 8. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, Lesage AS.
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [Abstract] [Full Text] [Related]

  • 9. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
    Kendall DA, Taylor DP, Enna SJ.
    Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
    [Abstract] [Full Text] [Related]

  • 10. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
    Nelson DL, Pedigo NW, Yamamura HI.
    J Physiol (Paris); 1981 May; 77(2-3):369-72. PubMed ID: 7288652
    [Abstract] [Full Text] [Related]

  • 11. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL, Liu MT, Howard MJ, Gershon MD.
    J Comp Neurol; 1993 Jan 08; 327(2):233-50. PubMed ID: 8425944
    [Abstract] [Full Text] [Related]

  • 12. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ, Trivedi BL, de Paulis T, Schmidt DE, Hewlett WA.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb 08; 365(2):123-32. PubMed ID: 11819030
    [Abstract] [Full Text] [Related]

  • 13. Ascorbate modulates 5-[3H]hydroxytryptamine binding to central 5-HT3 sites in bovine frontal cortex.
    Todd RD, Bauer PA.
    J Neurochem; 1988 May 08; 50(5):1505-12. PubMed ID: 3361306
    [Abstract] [Full Text] [Related]

  • 14. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ, Hamik A, Harrington MA, Hoffman AJ, Mathis CA, Pierce PA, Wang SS.
    Mol Pharmacol; 1988 Oct 08; 34(4):537-42. PubMed ID: 3173334
    [Abstract] [Full Text] [Related]

  • 15. Artifactual high-affinity and saturable binding of [3H]5-hydroxytryptamine induced by radioligand oxidation.
    Peroutka SJ, Ison PJ, Liu DU, Barrett RW.
    J Neurochem; 1986 Jul 08; 47(1):38-45. PubMed ID: 3711910
    [Abstract] [Full Text] [Related]

  • 16. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G.
    Mol Pharmacol; 1996 Oct 08; 50(4):752-62. PubMed ID: 8863819
    [Abstract] [Full Text] [Related]

  • 17. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE.
    J Physiol (Paris); 1981 Oct 08; 77(2-3):351-62. PubMed ID: 7288650
    [Abstract] [Full Text] [Related]

  • 18. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 08; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 19. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR, Gregory CM.
    Cytobios; 1993 Jul 08; 75(302-303):197-209. PubMed ID: 8243108
    [Abstract] [Full Text] [Related]

  • 20. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
    McKenna DJ, Peroutka SJ.
    J Neurosci; 1989 Oct 08; 9(10):3482-90. PubMed ID: 2795135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.